Post #213

Profluent just raised $106M led by Jeff Bezos to make biology programmable. Founder Ali Madani started at Salesforce's moonshot ProGen project in 2020, left in 2022, and partnered with UW researcher Alexander Meeske. • $106M Series B (Bezos Expeditions, Altimeter) • Approaching $1B valuation • 115B protein database (largest globally) • Partners: Revvity ($11B), Corteva, Ensoma • AI models design custom proteins from human language How it happened: • Identified AI-biology convergence pre-ChatGPT boom • Published Nature Biotechnology paper establishing credibility • Left corporate to focus full-time with academic co-founder • Built massive proprietary dataset (115B proteins) • Proved scaling laws work for protein design • Secured commercial partnerships before major funding https://www.forbes.com/sites/amyfeldman/2025/11/19/jeff-bezos-is-backing-an-ai-startup-aiming-to-make-proteins-programmable/ Takeaway: Academic research + commercial partnerships + proprietary data = billion-dollar biotech validation. Source: Forbes Brewed by Startup Beaker.